Last reviewed · How we verify

NCT05016193

Independent Use of Brain Measurement-Based Rehabilitation System by Stroke Survivors

Completed NA Last updated 13 August 2024
What this trial tests

NA trial testing Axem Home Prototype Device in Stroke in 30 participants. Completed in 9 August 2024.

Timeline
1 August 2021
Primary endpoint
1 August 2024
9 August 2024

Quick facts

Lead sponsorUniversity of Calgary
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment30
Start date1 August 2021
Primary completion1 August 2024
Estimated completion9 August 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Calgary

Who can join

Adults 18 to 99, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Axem Home study is a randomized open label trial analyzing the safety and feasibility of coupling the Axem Home prototype device with exercise to improve motor recovery following a stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Calgary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05016193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing